Research output per year
Research output per year
Personal profile
Headline
PROFESSOR | Neurology
Fingerprint
Dive into the research topics where Aaron Miller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cognitive effects of ocrelizumab vs interferon β-1a in relapsing multiple sclerosis: A post hoc analysis of the OPERA I/II trials
Benedict, R. H., Kappos, L., Miller, A., Hartung, H. P., Overell, J., Pei, J., Dahlke, F., Bernasconi, C., Koendgen, H., Wang, Q., Bonati, U. & Cohan, S., Mar 2025, In: Multiple Sclerosis and Related Disorders. 95, 106310.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial
Corboy, J. R., Fox, R. J., Cutter, G., Engebretson, E., Miller, A., Morgan, C., Gustafson, T., Goodman, A. D., Kannan, M., Sriram, S., Xia, Z., Lynch, S., Bowen, J. & Kister, I., Feb 2025, In: Multiple Sclerosis Journal. 31, 2, p. 159-173 15 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?
Miller, A. E., Apr 2024, In: Multiple Sclerosis Journal. 30, 4-5, p. 479-482 4 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Katz Sand, I., Gnjatic, S., Krammer, F., Tuballes, K., Carreño, J. M., Satyanarayan, S., Filomena, S., Staker, E., Tcheou, J., Miller, A., Fabian, M., Safi, N., Nichols, J., Patel, J., Krieger, S., Tankou, S., Horng, S., Klineova, S., Beck, E. & Merad, M. & 1 others, , Feb 2023, In: Multiple Sclerosis and Related Disorders. 70, 104486.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
Multiple sclerosis progression: time for a new mechanism-driven framework
International Advisory Committee on Clinical Trials in Multiple Sclerosis, Jan 2023, In: The Lancet Neurology. 22, 1, p. 78-88 11 p.Research output: Contribution to journal › Review article › peer-review
391 Scopus citations
Press/Media
-
-
U.S. Patents Awarded to Inventors in New York (May 1)
Lee, J., Miller, A., Lee, J. & Lee, R.
1/05/24
1 item of Media coverage
Press/Media
-
Pending FDA Decisions in Neurology to Watch in the First Half of 2024
29/01/24
1 item of Media coverage
Press/Media